Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)
Japan · Delayed Price · Currency is JPY 97.00
+2.00 (2.11%)
Apr 17, 2026, 3:30 PM JST
Kubota Pharmaceutical Holdings Company Description
Kubota Pharmaceutical Holdings Co., Ltd. engages in the pharmaceutical and medical device business worldwide.
The company offers eyeMO, a remote retinal monitoring device for home-based and patient self-monitoring optical coherence tomography; and a NASA high-res version OCT device.
It also provides Emixustat HCI compounds for Stargardt disease indications in Phase 3 clinical trials, as well as proliferative diabetic retinopathy and diabetic macular edema in Phase 2 clinical trials.
The company was founded in 2002 and is headquartered in Minato, Japan.
Kubota Pharmaceutical Holdings Co., Ltd.
| Country | Japan |
| Founded | 2002 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Ryo Kubota |
Contact Details
Address: 1-15-37 Minami-Aoyama Minato, 107-0062 Japan | |
| Phone | 81 3 6550 8928 |
| Website | kubotaholdings.co.jp |
Stock Details
| Ticker Symbol | 4596 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | JPY |
| ISIN Number | JP3266500002 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ryo Kubota | Chief Executive Officer |
| Tomomi Sukagawa | Head of Investor Relations |